Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma
Filip, D., Litzmanova, K., Michaelou, A., Kledus, F., Devan, J., Boudny, M., Hoferkova, E., Sharma, S., Seda, V., Zeni, P. F., Borsky, M., Matulova, K., Kren, L., Oppelt, J., Blavet, N., Hejret, V., Urik, M., Mareckova, A., Rimsza, L. M. & Kamaradova, K. & 14 others, , 2026, (Accepted/In press) In: Leukemia.Research output: Contribution to journal › Article › peer-review
Open Access -
Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial
Shadman, M., LeBlanc, M., Rimsza, L., Leonard, J. P., Smith, S. M., Li, H. & Friedberg, J. W., 2026, (Accepted/In press) In: JAMA Oncology.Research output: Contribution to journal › Article › peer-review
Open Access -
A Bootstrap Method to Estimate Cost of Behavioral Intervention Implementation: A Proof of Concept
Mo, J., Maeng, D., Hornbrook, M. C., Sun, V., McCorkle, R. C., Weinstein, R. S. & Krouse, R. S., Aug 2025, In: Health Services Research. 60, 4, e14608.Research output: Contribution to journal › Article › peer-review
Open Access
-
HORMONAL REGULATION OF CARCINOGENESIS IN TROUT
Nelson, M. A. (PI) & Buhler, D. (PI)
3/1/91 → …
Project: Research project
-
Development of Mantle Cell Lymphoma Proliferation Signature Assay
Rimsza, L. M. (PI)
Project: Research project
-
Development of Mantle Cell Lymphoma Proliferation Signature Assay
Rimsza, L. M. (PI)
Project: Research project
Datasets
-
Regions of acquired UPD at diagnosis of FL are associated with both overall survival and risk of transformation
O'Shea, D. M. (Contributor), Yang, Y. (Contributor), Gribben, J. G. (Contributor), Rosenwald, A. (Contributor), Ott, G. (Contributor), Campo, E. (Contributor), Rimsza, L. M. (Contributor), Chan, W. C. (Contributor), Johnson, N. (Contributor), Gascoyne, R. D. (Contributor), Staudt, L. M. (Contributor) & Fitzgibbon, J. (Contributor), Gene Expression Omnibus, Jan 27 2009
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE14582
Dataset
-
Comparison of type 1 conventional dendritic cells pre-cDC1 and CD8+ cDC1 and dendritic cells from bendamustine- or cyclophosphamide-treated mice
Molina, M. S. (Creator) & Katsanis, E. (Creator), University of Arizona Research Data Repository, 2021
DOI: 10.25422/azu.data.14241902, https://arizona.figshare.com/articles/dataset/Comparison_of_type_1_conventional_dendritic_cells_pre-cDC1_and_CD8_cDC1_and_dendritic_cells_from_bendamustine-_or_cyclophosphamide-treated_mice/14241902
Dataset
-
Supplementary Material for: A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma
Puvvada, S. D. (Creator), Guillén-Rodríguez, J. M. (Creator), Rivera, X. I. (Creator), Heard, K. (Creator), Inclan, L. (Creator), Schmelz, M. (Creator), Schatz, J. H. (Creator) & Persky, D. O. (Creator), Karger Publishers, 2017
DOI: 10.6084/m9.figshare.5373199.v1, https://karger.figshare.com/articles/figure/Supplementary_Material_for_A_Phase_II_Exploratory_Study_of_PXD-101_Belinostat_Followed_by_Zevalin_in_Patients_with_Relapsed_Aggressive_High-Risk_Lymphoma/5373199/1
Dataset